Tesla Halts Orders for $61K Cybertruck, Pushes $100K Modelby Mark Eisenberg 10.08.2024Tesla stops taking orders for $61K Cybertruck, focuses on $100K model with near-immediate delivery options.
Hospice Center Uses VR for Enhanced Patient Experienceby Lilu Anderson 07.08.2024A hospice center in Yuma introduces VR to offer mobility-limited patients therapeutic benefits and mental relief.
Influencer Gifts Trump a Tesla, Rolex, & Legal Troubleby Mark Eisenberg 06.08.2024"Influencer Adin Ross gifts Trump a Tesla and Rolex, sparking potential campaign finance violation inquiry. What consequences could Trump face?"
Aerovate Therapeutics Stock Downgraded After Trial Setbackby Mark Eisenberg 17.06.2024Aerovate Therapeutics stock downgraded by BTIG after AV-101 trial setback; mixed analyst views and future pivotal readouts crucial for investors.
Gilead Acquires CymaBay: Liver Cure Leap?by Mark Eisenberg 12.02.2024Gilead Sciences acquires CymaBay Therapeutics for $4.3 billion to expand its liver disease portfolio, including access to potential treatment for ...
Bristol Myers Bags RayzeBio in $4.1B Cancer Fight Pactby Mark Eisenberg 12.02.2024Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
AN2 Therapeutics Pauses Trial: Efficacy Concerns Riseby Mark Eisenberg 12.02.2024AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...